So, what happens if we restore pyrimidines to these cells?
A complete loss of the ASP rebound and a return to the (very reasonable) phenotype of monotonic ASP depletion.
So, SDH loss causes a disproportionate effect on pyrimidine synthesis by impairing ATCase, but why?
A complete loss of the ASP rebound and a return to the (very reasonable) phenotype of monotonic ASP depletion.
So, SDH loss causes a disproportionate effect on pyrimidine synthesis by impairing ATCase, but why?
Comments
https://pubmed.ncbi.nlm.nih.gov/3894357/
Conclusion: succinate competes with diminished ASP at ATCase, blocking pyrimidine synthesis. To our knowledge the first description of this relationship in cells + revealing another potential regulatory function of succinate.